 This research has developed a new drug delivery system for treating sepsis. The system consists of a nanocarrier made from polydopamine, which releases two drugs, NAD+, and BAPDAM, when it comes into contact with inflamed tissue. These drugs work together to reduce inflammation, restore cellular homeostasis, and prevent organ damage caused by sepsis. This novel approach could be used to treat patients suffering from sepsis, potentially saving lives.